Sung, J., Cheong, J., Shin, K., & Kim, E. T. A subtype of cancer‐associated fibroblast expressing syndecan‐2 (SDC2) predicts survival and immune checkpoint inhibitor response in gastric cancer. Wiley.
Chicago Style (17th ed.) CitationSung, Ji‐Yong, Jae‐Ho Cheong, Kihye Shin, and Eui Tae Kim. A Subtype of Cancer‐associated Fibroblast Expressing Syndecan‐2 (SDC2) Predicts Survival and Immune Checkpoint Inhibitor Response in Gastric Cancer. Wiley.
MLA (9th ed.) CitationSung, Ji‐Yong, et al. A Subtype of Cancer‐associated Fibroblast Expressing Syndecan‐2 (SDC2) Predicts Survival and Immune Checkpoint Inhibitor Response in Gastric Cancer. Wiley.
Warning: These citations may not always be 100% accurate.